Should the presence of germline BRCA1/2 mutations influence treatment selection in breast cancer? Editorial Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Genes, BRCA1

publication date

  • October 2011

Research

keywords

  • Editorial

Identity

Digital Object Identifier (DOI)

  • 10.1200/JCO.2011.37.2540

PubMed ID

  • 21900108

Additional Document Info

start page

  • 3724

end page

  • 6

volume

  • 29

number

  • 28